Evaluation of the effect of human β-defensins on neutrophil apoptosis

International Immunology

Volumn 20, Issue 4, 2008, Pages 543-553

  Nagaoka, Isao ^a   Niyonsaba, François ^a   Tsutsumi Ishii, Yuko ^a   Tamura, Hiroshi ^b   Hirata, Michimasa ^c  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

^c Insititute of Ohtaka Enzyme Co   (Japan)

Author keywords

Antimicrobial peptides; Chemokine receptor; Innate immunity

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CALCIUM ION; CASPASE 3; CHEMOKINE; CHEMOKINE RECEPTOR CCR6; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCLONAL ANTIBODY; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN BCL XL; PROTEIN BID; TUMOR NECROSIS FACTOR ALPHA;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL TRANSMISSION; BACTERICIDAL ACTIVITY; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL STRAIN HEK293; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EFFECTOR CELL; EMBRYO; ENZYME ACTIVITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATORY CELL; INHIBITION KINETICS; INNATE IMMUNITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; APOPTOSIS; BCL-X PROTEIN; BETA-DEFENSINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CALCIUM; CASPASE 3; CYTOKINES; ENZYME ACTIVATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MITOCHONDRIAL MEMBRANES; NEUTROPHILS; RECEPTORS, CCR6;

EID: 41149111364     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn012     Document Type: Article

References (55)

1. Hancock, R. E.W. and Diamond, G. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402.
2. Ganz, T 2003. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev Immunol. 3:710.
3. Selsted, M. E. and Ouellette, A. J. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551.
4. Gennaro, R. and Zanetti, M. 2000. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55:31.
5. Niyonsaba, F., Nagaoka, I. and Ogawa, H. 2006. Human defensins and cathelicidins in the skin: Beyond direct antimicrobial properties. Crit. Rev. Immunol. 26:545.
6. Zhao, C., Wang, I. and Lehrer, R. I. 1996. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396:319.
7. Fulton, C., Anderson, G. M., Zasloff, M., Bull, R. and Quinn, A. 1997. Expression of natural peptide antibiotics in human skin. Lancet 350:1750.
8. Harder, J., Bartels, J., Christophers, E. and Schröder, J. M. 1997. A peptide antibiotic from human skin. Nature 387:861.
9. Liu, A. Y., Destoumieux, D., Wong, A. V. et al. 2002. Human β-defensin-2 production in keratinocyters is regulated by interleukin-1, bacteria, and the state of differentiation. J. Invest. Dermatol. 118:275.
10. Harder, J., Bartels, J., Christophers, E. and Schröder, J. M. 2001. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707.
11. García, J. R.C., Jaumann, F, Schulz, S. et al. 2001. Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306:257.
12. García, J. R.C., Krause, A., Schulz, S. et al. 2001. Human β-defensin 4: A novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 15:1819.
13. Harder, J., Meyer-Hoffer, U., Wehkamp, K., Schwichtenberg, L. and Schröder, J. M. 2004. Differential gene induction of human β-defensins (hBD-1,-2,-3, and -4) in keratinocytes is inhibited by retinoic acid. J. Invest. Dermatol. 123:522.
14. Yang, D., Biragyn, A., Kwak, L. W. and Oppenheim, J. J. 2002. Mammalian defensins in immunity: More than just microbicidal. Trends Immunol. 23:291.
15. Dürr, M. and Peschel, A. 2002. Chemokines meet defensins: The merging concepts of chemoattractants and antimicrobial peptides. Infect. Immun. 70:6515.
16. Niyonsaba, F., Ushio, H., Nagaoka, I., Okumura, K. and Ogawa, H. 2005. The human β-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J. Immunol. 175:1776.
17. Niyonsaba, F., Ushio, H., Nakano, N. et al. 2007. Antimicrobial peptides human β-defensins stimulate epidermal keratinocytes migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127:594.
18. Yamaguchi, Y., Nagase, T., Makita, R. et al. 2002. Identification of multiple epididymis-specific β-defensin isoforms in human and mice. J. Immuol. 169:2516.
19. Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B. and Salcedo, R. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238:325.
20. Yang, D., Chertov, O. and Oppenheim, J. J. 2001. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 69:691.
21. Bowdish, D. M.E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G. and Hancock, R. E.W. 2005. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77:451.
22. Smith, J. A. 1994. Neutrophils, host defense, and inflammation: A double-edged swords. J. Leukoc. Biol. 56:672.
23. Whyte, M., Renshaw, S., Lawson, R. and Bingle, C. 1999. Apoptosis and the regulation of neutrophil lifespan. Biochem. Soc. Trans. 27:802.
24. Akgul, C., Moulding, D. A. and Edwards, S. W. 2001. Molecular control of neutrophil apoptosis. FEBS Lett. 487:318.
25. Simon, H. U. 2003. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol. Rev. 193:101.
26. Colotta, F., Re, F., Polentarutti, N., Sozzani, S. and Mantovani, A. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012.
27. Oberholzer, C., Oberholzer, A., Clare-Salzler, M. and Moldawer, L. L. 2001. Apoptosis in sepsis: A new target for therapeutic exploration. FASEB J. 15:879.
28. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420:885.
29. Gamberale, R., Giordano, M., Trevani, A. S., Andonegui, G. and Geffner, J. R. 1998. Modulation of human neutrophil apoptosis by immune complexes. J. Immunol. 161:3666.
30. Allen, L., Dockrell, D. H., Pattery, T. et al. 2005. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J. Immunol. 174:3643.
31. 7. J. Immunol. 176:3044.
32. Barlow, P. G., Li, Y., Wilkinson, T S. et al. 2006. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J. Leukoc. Biol. 80:509.
33. Niyonsaba, F., Ogawa, H. and Nagaoka, I. 2004. Human β-defensin-2 functions as a chemotactic agent for tumor necrosis factor-α-treated human neutrophils. Immunology 111:273.
34. Zlotnik, A. and Yoshie, O. 2000. Chemokines: A new classification system and their role in immunity. Immunity 12:121.
35. Majewska, E., Sulowska, Z. and Baj, Z. 2000. Spontaneous apoptosis of neutrophils in whole blood and its relation to apoptosis gene proteins. Scand. J. Immunol. 52:496.
36. Cossarizza, A., Baccarani-Contri, M., Kalashnikova, G. and Franceschi, C. 1993. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro- 1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197:40.
37. Niyonsaba, F. and Iwabuchi, 2002., K., Someya, A. et al. 2002. A cathelicidin family of human antibacterial peptide LL-37 induces mast call chemotaxis. Immunology 106:20.
38. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770.
39. Nagaoka, I., Yomogida S., Tamura, H. and Hirata, M. 2004. Antibacterial cathelicidin peptide CAP11 inhibits the lipopolysaccharide (LPS)-induced suppression of neutrophil apoptosis by blocking the binding of LPS to target cells. Inflamm. Res. 53:609.
40. Wu, Z., Hoover, D. M., Yang, D. et al. 2003. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3. Proc. Natl Acad. Sci. USA 100:8880.
41. Li, H., Zhu, H., Xu, C. J. and Yuan, J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491.
42. Lamothe, B. and Aggarwal, B. B. 2002. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. J. Interferon Cytokine Res. 22:269.
43. Matsuzaki, K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462:1.
44. Yang, D., Chen, Q., Schmidt, A. P. et al. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemo-attract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192:1069.
45. 7 receptor activator, the human cathelicidin-derived peptide LL-37, induces IL-1β processing and release. J. Immunol. 172:4987.
46. 6 signaling pathway. Blood 107:2936.
47. Schaller-Bals, S., Schulze, A. and Bals, R. 2002. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am. J. Respir. Crit; Care Med. 165:992.
48. Chen, C. I. U., Schaller-Bals, S., Paul, K. P., Wahn, U. and Bals, R. 2004. β-Defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J. Cyst. Fibros 3:45.
49. Ong, P. Y., Ohtake, T., Brandt, C. et al. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151.
50. Paulsen, F., Pufe, T., Conradi, L. et al. 2002. Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J. Pathol. 198:369.
51. Kiehne, K., Brunke, G., Meyer, D., Harder, J. and Herzig, K. H. 2005. Oesophageal defensin expression during Candida infection and reflux disease. Scand. J. Gastroenterol. 40:501.
52. Theilgaard-Mönch, K., Knudsen, S., Follin, P. and Borregaard, N. 2004. The transcriptional activation program of human neutrophils in skin lesions supports their important role in wound healing. J. Immunol. 172:7684.
53. Zychlinsky, A. and Sansonetti, P. 1997. Apoptosis in bacterial pathogenesis. J. Clin. Invest. 100:493.
54. Sun, C. Q., Arnold, R., Fernandez-Golarz, C. et al. 2006. Human β-defensin-1, a potential chromosome 8p tumor suppressor: Control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res. 66:8542.
55. Yamaguchi, Y., Nagase, T., Tomita, T. et al. 2007. β-Defensin overexpression induces progressive muscle degeneration in mice. Am. J. Physiol. Cell Physiol. 292:C2141.